Dating prostate cancer
However, only about half of men will experience objective responses and one-third will benefit from pain palliation, leaving room for improvement.
Adding something novel to docetaxel in a ‘plus or minus’ clinical trial design has become extremely popular, typically with a targeted or otherwise novel therapeutic agent.
ZERO is proud to partner with Summit Urology Group to end prostate cancer.
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.
October 13-15, 2017 NASPCC brings in one representative per state prostate cancer coalition for a weekend-long networking and educational event.